NVAX - NovavaxAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $231.23 | Open | $238.24 |
| Volume | 1.22M | Market Cap | 14.101B |
| Yield | Last Dividend |
| This Week's Stars Are Zoom, Target And C... | 12:59 PM |
| Zoom Video Communications Inc (NASDAQ: ZM ) will open the week on Monday after market close whereas big-box retailers highlight the week's other big r... | |
| Novavax???s share price: What to expect ... | 8:35 AM |
| Can fourth-quarter earnings deliver a shot of adrenaline to Novavax???s share price? | |
| Novavax Does Earnings Surprise History H... | 7:00 AM |
| Novavax announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Russia & West Trade Blame For Vaccine 'P... | 02/26/21 |
| Russia & West Trade Blame For Vaccine 'Price Gouging' & Exploitation Of Africa Westerners bringing 'benefits' to the African continent has long been m... | |
| Dr Glen from Novavax is in UK. Working f... | 02/26/21 |
| Dr Glen from Novavax is in UK. Working for UK EUA. Start from 1:09:00 ??? chatter @ #wallstreetbets | |
| Tie-up with Serum Institute key to mass ... | 02/24/21 |
| A senior official from AstraZeneca told a US house panel that along with Novavax and SII, it planned to supply 300 million doses globally | |
| Tie-up with Serum Institute Key to Mass ... | 02/24/21 |
| British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of C... | |
| 'Ready to scale up production of COVID-1... | 02/24/21 |
| British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of C... | |
| AstraZeneca, Novavax ready to team up wi... | 02/24/21 |
| Located in the city of Pune in Maharashtra, the SII is the world's largest vaccine manufacturer by volume | |
| Takeda starts clinical trial of Novavax ... | 02/24/21 |
| The drugmaker said it expects to gain results from a study on 200 Japanese participants age 20 or older in the second half of this ??? | |
| Novavax expects US trial data for COVID-... | 02/24/21 |
| Novavax Inc expects data from a late-stage U.S. trial of its COVID-19 vaccine at the start of April, after which it will apply for emergency use autho... | |
| With Novavax vaccine deal under its belt... | 02/24/21 |
| It pays to be in the Covid-19 vaccine manufacturing business. Shortly after it announced an expanded deal to produce 40 million doses of Novavax's Cov... | |
| More jabs on way: 3 cos to file final da... | 02/23/21 |
| Three companies ??? Biological E, Dr Reddy???s Laboratories and Serum Institute of India ??? are preparing to submit data for approval of their Covid-... | |
| Novavax Nears Covid-19 Vaccine Game Chan... | 02/23/21 |
| Scientists believe that if authorized, Novavax???s vaccine could be one of the more powerful weapons against the pandemic. It would be a shift in fort... | |
| WATCH: MP asks Prime Minister when Novav... | 02/23/21 |
| ON Monday an MP asked the Prime Minister when Medicines and Healthcare products Regulatory Agency (MHRA) approval would be expected for the Novavax??? | |
| FXNEWS24 |Novavax completes enrollment i... | 02/22/21 |
| Novavax completes enrollment in Phase 3 clinical trial for its COVID-19 vaccine candidate | UK Stocks, Forex, Commodities, Crypto, Live Market News- D... | |
| Novavax completes enrollment in Phase 3 ... | 02/22/21 |
| Shares of Novavax Inc. undefined were down 6.2% in trading on Monday after the company said it had completed enrollment of the Phase 3 clinical trial ... | |
| Novavax completes enrolling 30,000 peopl... | 02/22/21 |
| Novavax has deals to produce the two-shot vaccine, which is under real-time review in the European Union, at several manufacturing locations, includin... | |
| Supply deals with 3 vaccine makers seen ... | 02/22/21 |
| MANILA, Philippines--- The government is expected to sign supply agreements with three COVID-19 vaccine makers before the end of the month, senators l... | |
| Novavax Achieves Target Enrollment In Pi... | 02/22/21 |
| Novavax, Inc. (NASDAQ: NVAX ) has taken another step toward obtaining emergency use authorization for NVX-CoV2373, its recombinant protein-based vacci... | |
| Health Ministry Agrees With Indian Serum... | 02/22/21 |
| The Health Ministry of Ukraine has agreed with Serum Institute (the Republic of India) on the delivery of additional 5 million doses of the NovaVax va... | |
| Ukraine expects 15 million Novavax doses... | 02/22/21 |
| KYIV, Feb 22 ??? Ukraine has agreed to increase the number of Covid-19 vaccine doses with US maker Novavax to 15 million, Health Minister Maksym Stepa... | |
| Buy rating | 02/18/21 |
| B. Riley FBR maintains Buy rating and raises Price Target from $334.00 to $397.00 | |
| Strong Buy rating | 02/05/21 |
| Cantor Fitzgerald maintains Overweight rating and raises Price Target from $248.00 to $338.00 | |
| Buy rating | 02/01/21 |
| B. Riley FBR maintains Buy rating and raises Price Target from $223.00 to $334.00 | |
| Buy rating | 12/14/20 |
| Jefferies initiates coverage with Buy rating and announces Price Target of $200.00 | |
| Date | Today (AMC) | Est. (EPS/Rev.) | ($1.49)/ 304.88M |
| Actual (EPS/Rev.) | / | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Pennies | Mmkt0652 | 84.00 % | Follow |
| Trading Systems | Trading Systems | 84.00 % | Subscribe |
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Tech Trades | Tech Trades | 81.00 % | Follow |
| Option Superstars | James Catzen | 76.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
